Tiziana Life Sciences share price logo

Tiziana Life Sciences

NASDAQ: TLSA

$1.05

as on

Tiziana Life Sciences Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.03
    $1.10
    downward going graph

    1.90%

    Downside

    4.76%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.76
    $2.10
    downward going graph

    27.48%

    Downside

    100.00%

    Upside

    downward going graph

Tiziana Life Sciences share price movements today

Previous Close
$1.05
Open
$1.06
Volume
1.9M
Market Cap
$133.6M
Day's Low - High
$1.03 - $1.10
52 Week Low - High
$0.76 - $2.10

Tiziana Life Sciences Historical Returns

1 Month Return
+ 8.25 %
3 Month Return
-1.87 %
1 Year Return
-46.15 %
3 Year Return
+ 43.64 %
5 Year Return
-30.46 %

Tiziana Life Sciences Stock Fundamentals & Key Indicators

Check Tiziana Life Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$133.6M

EPS (TTM)

-0.3164

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.32

Industry PE ratio

-3.95

PEG Ratio

0.12

EBITDA

-17.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-398.42%

Tiziana Life Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tiziana Life Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Tiziana Life Sciences image
Tiziana Life Sciences
Buy$133.6M-30.46%-3.320.00%0.00%
Moderna image
Moderna
Neutral$94.4B-32.76%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.9B174.93%29.3786.04%0.00%
Regeneron image
Regeneron
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Tiziana Life Sciences Stock including INR - Dollar returns

The Tiziana Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Tiziana Life Sciences investment value today

Current value as on today

₹58,103

Returns

-₹41,897

(-41.9%)

Returns from Tiziana Life Sciences Stock

-₹46,154 (-46.15%)

Dollar Impact

₹4,257 (+4.26%)

Analyst Recommendation on Tiziana Life Sciences Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Tiziana Life Sciences. Average target price of $8.02

Tiziana Life Sciences Share Price Target

Get share price movements and forecasts by analysts on Tiziana Life Sciences.

What analysts predicted

86.91%UPSIDE

Target Price

$8.02

Current Price

$1.05

Analyzed by

1 Analysts

High

$7

Target

$8.02

Low

$7

Tiziana Life Sciences target price $8.02, a slight upside of 86.91% compared to current price of $1.05. According to 1 analysts rating.

Indian Investors' Interest in Tiziana Life Sciences Stock

Search interest for Tiziana Life Sciences Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

Tiziana Life Sciences Quarterly Profit & Loss

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
0
0
0
0
0
0
0
0
Operating Income
-21
-5
-5
-12
-14
-6
-12
-9
-8
-12
EBITDA
-21
-5
-5
-13
-10
-8
-15
-8
-5
-12
Interest Expense
0
-
-
0
0
0
-
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-4
-5
-13
-10
-8
-15
-8
-5
-12
Income Tax Expense
-
-
-
-
-
0
-6
-1
-
-
Net Income
-17
-3
-5
-13
-10
-9
-9
-7
-5
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tiziana Life Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-8
-9
-9
-38
-36
-17
-22
-15
-21
EBITDA
-8
-9
-9
-37
-35
-18
-21
-16
-18
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-9
-10
-38
-35
-18
-21
-16
-18
Income Tax Expense
-1
-1
0
-3
-4
-
0
-4
-
Net Income
-6
-7
-9
-35
-31
-18
-22
-11
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tiziana Life Sciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
-8
-2
-3
-8
-6
-7
-3
-5
-5
-12
Operating Cash Flow
-13
-4
-9
-6
-8
-3
0
-1
-6
-6
Investing Cash Flow
0
-1
-2
0
0
0
0
0
2
0
Financing Cash Flow
0
0
0
0
0
0
0
3
7
2
Change in Cash
-12
-52
-22
-6
-9
-4
0
2
3
-3

Tiziana Life Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-7
-7
-19
-17
-12
-13
-9
-18
Operating Cash Flow
-5
-4
-5
-8
-16
-15
-12
-1
-12
Investing Cash Flow
0
-
0
0
0
-3
0
0
3
Financing Cash Flow
1
10
1
54
0
0
0
3
10
Change in Cash
-4
5
-3
48
-17
-19
-13
2
0

Global Institutional Holdings in Tiziana Life Sciences

Check out the Institutions with significant holdings in Tiziana Life Sciences.

Funds
Holdings
Fidelity Concord Street Trust
0.06%
GOLDMAN SACHS TRUST
0.04%

Tiziana Life Sciences News & Key Events

  • img

    Today's Timeline - 30 September

    Wed, 04:45 PM

    -

    Tiziana Life Sciences submits request for Orphan Drug Designation for intranasal foralumab in treating Multiple System Atrophy.

Insights on Tiziana Life Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TLSA stock has moved up by 15.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 114.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 784.4%

About Tiziana Life Sciences

Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.
OrganisationTiziana Life Sciences
Headquarters14/15 Conduit Street, London, W1S 2XJ, GB
IndustryBiotechnology
CEOIvor R. Elrifi

Key Management of Tiziana Life Sciences

Name

Title

Ms. Keeren Shah

COO & CFO

Dr. Ivor R. Elrifi Ph.D.

CEO & Executive Director

Mr. William Edward Tente M.S.

Chief Regulatory Officer

Dr. Richard K. Kim M.D.

Chief Medical Officer

Dr. Napoleone Ferrara M.D.

Member of Scientific Advisory Board

Mr. Gabriele Marco Antonio Cerrone M.B.A.

Founder & Executive Chairman

FAQs

What is Tiziana Life Sciences share price today?

Tiziana Life Sciences share price today is $1.05 as on at the close of the market. Tiziana Life Sciences share today touched a day high of $1.10 and a low of $1.03.

What is the 52 week high and 52 week low for Tiziana Life Sciences share?

Tiziana Life Sciences share touched a 52 week high of $2.10 on and a 52 week low of $0.76 on . Tiziana Life Sciences stock price today i.e. is closed at $1.05,which is 50.00% down from its 52 week high and 37.89% up from its 52 week low.

What is Tiziana Life Sciences's market capitalisation today?

Tiziana Life Sciences market capitalisation is $0.00T as on .

How to invest in Tiziana Life Sciences Stock (TLSA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tiziana Life Sciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Tiziana Life Sciences Stock (TLSA) from India?

Indian investors can start investing in Tiziana Life Sciences (TLSA) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Tiziana Life Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Tiziana Life Sciences share’s latest price of $1.05 as on October 17, 2026 at 8:46 am IST, you will get 9.5238 shares of Tiziana Life Sciences. Learn more about fractional shares .

What are the returns that Tiziana Life Sciences has given to Indian investors in the last 5 years?

Tiziana Life Sciences stock has given -30.46% share price returns and 26.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?